Clinical Trials Logo
  1. Home
  2. Chronic Coronary Syndrome
  3. NCT05978089

Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）

Chronic Coronary Syndrome Clinical Trial

Official title:
Efficacy and Safety of Yangxinshi Tablet in Improving Exercise Tolerance in Patients With Chronic Coronary Syndrome(Qi Deficiency and Blood Stasis Syndrome):A Randomized, Double-blind,Placebo-parallel-controlled,Multicenter Clinical Study

Clinical Trial Summary

This study adopted a randomized, double-blind, placebo-controlled, multicenter clinical design and compared the effects of Yangxinshi tablet and placebo on exercise tolerance in patients with chronic coronary syndrome (CCS).

Clinical Trial Description

The aim of the research is to find out if the addition of Yangxinshi tablets on the basis of conventional treatment can improve exercise tolerance of patients with chronic coronary syndrome (CCS), improve quality of life and mental health. A total of 120 qualified CCS patients were randomly divided into two groups. In addition to conventional treatment, the experimental group was given Yangxinshi tablets (3 tablets/time and 3 times/day), and the control group was given Yangxinshi tablet simulants (3 tablets/time and 3 times/day). The treatment period was 24 weeks. The primary endpoints were metabolic equivalents (METs), and peak oxygen uptake measured by cardiopulmonary exercise testing after 24 weeks of treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05978089
Study type Interventional
Source Dongzhimen Hospital, Beijing
Contact Wang Xian
Phone 010-84013276
Email wx650515@163.com
Status Recruiting
Phase Phase 4
Start date November 8, 2023
Completion date December 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06185530 - SECURE Trial: Stress Echocardiography With Carotid Ultrasound vs Routine CT Coronary Angiography in Chronic Coronary Syndrome for Endpoints N/A
Recruiting NCT05117866 - Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study N/A
Recruiting NCT05727982 - Identification of Molecular Mechanisms of Coronary Instability in Homogeneous Subsets of Patients With Acute Coronary Syndromes for the Implementation of Precision Medicine
Recruiting NCT03936504 - Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model N/A
Recruiting NCT05865600 - Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome N/A
Recruiting NCT06337461 - Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography
Recruiting NCT05640752 - Optimal Evaluation to Reduce Imaging Testing N/A
Recruiting NCT05635994 - Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
Not yet recruiting NCT05875311 - Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC) N/A
Recruiting NCT05583786 - Intracoronary ECG ST-segment Shift Remission Time During Reactive Coronary Hyperemia
Completed NCT05592535 - Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome
Recruiting NCT06255678 - Angio-based Final Functional Effect of PCI
Recruiting NCT06275399 - Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery
Withdrawn NCT04738344 - Very Long Versus Overlapping Stents in Long Coronary Lesions N/A
Active, not recruiting NCT04135989 - Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES Phase 4
Recruiting NCT05674630 - Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons Phase 4
Not yet recruiting NCT06186336 - Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
Recruiting NCT06171061 - Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome Phase 4
Recruiting NCT05379608 - Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. N/A
Recruiting NCT05488249 - CCTA Coronary Hemodynamics, Systemic Inflammation and Vulnerable Plaques (COHESIVE)